• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YIN Minmin, YIN Zhiqi, ZHANG Jian, WANG Lei, YE Wencai. Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.[J]. Journal of China Pharmaceutical University, 2013, 44(3): 213-218. DOI: 10.11665/j.issn.1000-5048.20130305
Citation: YIN Minmin, YIN Zhiqi, ZHANG Jian, WANG Lei, YE Wencai. Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.[J]. Journal of China Pharmaceutical University, 2013, 44(3): 213-218. DOI: 10.11665/j.issn.1000-5048.20130305

Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.

More Information
  • Fourteen compounds were isolated and purified from ethyl acetate extract of Cynanchum otophyllum Schneid. , and were identified as otophylloside A( 1 ), otophylloside B( 2 ), 2, 5-dihydroxyacetophenone( 3 ), methyl 2, 5-dihydroxy-benzoate( 4 ), vanillin( 5 ), arjunolic acid( 6 ), glycosmisic acid( 7 ), caudatin-3-O-β-D- cymaropyranosyl-(1→4)-β-D-oleandropyranosl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside( 8 ), penupogenin( 9 ), caudatin-3-O-β-D-glucopyranosyl-(1 →4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside( 10 ), qingyangshengenin-3-O-β-D-oleandropyranosyl-(1→4)-β-D- cymaropyranosyl-(1→4)-β-D-digitoxopyranoside( 11 ), and kidjoranin-3-O-β-D- cymaropyranoside( 12 ), qingyangshengenin-3-O-β-D-cymaropyranosyl-(1→4)-β-D- digitoxopyranoside( 13 ), and kidjoranin-3-O-β-D-oleandropyranosyl-(1→4)-β-D- cymaropyranosyl-(1→4)-β-D-cymaropyranoside( 14 )by physicochemical properties and spectroscopic analyses. Among them, compounds 6-7 were firstly isolated from the genus Cynanchum, and compounds 3-5, 8-14 were isolated from this plant for the first time.
  • Related Articles

    [1]LI Hongxue, ZHANG Lei. Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014[J]. Journal of China Pharmaceutical University, 2016, 47(2): 247-250. DOI: 10.11665/j.issn.1000-5048.20160220
    [2]MAO Dan. Patent analysis of pharmaceutical cocrystals technology in China[J]. Journal of China Pharmaceutical University, 2015, 46(4): 509-512. DOI: 10.11665/j.issn.1000-5048.20150421
    [3]WANG Jingjing, WANG Huiyan, ZHANG Lingling, XIAO Jing, HU Weiguo, ZHANG Caixia, ZHOU Jie. Technical analysis of low molecule weight heparins patents and R&D suggestions[J]. Journal of China Pharmaceutical University, 2015, 46(4): 504-508. DOI: 10.11665/j.issn.1000-5048.20150420
    [4]X-Ray Diffraction Fourier Fingerprint Pattern Analysis for Qingkailing Patent Medicine[J]. Journal of China Pharmaceutical University, 2004, (2): 41-43.
    [5]Study on Related Substances and Stability of Ceftazidime and its Preparation[J]. Journal of China Pharmaceutical University, 2002, (2): 35-38.
    [6]System Separation of Cyclosporin A Triple Therapeutic Drugs by Micellar Electrokinetic Capillary Chromatography and Evaluation of Optimal Method Ruggedness[J]. Journal of China Pharmaceutical University, 1999, (5): 373-376.
    [7]HPLC Analysis of Metoprolol and Its Metabolites in the Perfusates[J]. Journal of China Pharmaceutical University, 1997, (6): 31-35.
    [8]NMR Analysis of Bromocriptine Mesilate Tenoxicam[J]. Journal of China Pharmaceutical University, 1997, (5): 33-35.
    [9]Studies on the Synthesis and Analysis of Impurities and Decomposition Product of Ondansetron Hydrochlorid[J]. Journal of China Pharmaceutical University, 1997, (4): 8-10.
    [10]The Preparation and Analysis of New Sweetener L-Asp-D-Ala-OiPr[J]. Journal of China Pharmaceutical University, 1997, (2): 114-115.

Catalog

    Article views (1148) PDF downloads (2067) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return